Literature DB >> 29549501

Colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai in patients with ulcerative colitis: a report of two cases.

Satoru Kondo1, Toshimitsu Araki2, Yoshiki Okita1, Akira Yamamoto1, Yasuhiko Hamada3, Masaki Katsurahara3, Noriyuki Horiki3, Misaki Nakamura4, Takahiro Shimoyama5, Takayuki Yamamoto5, Yoshiyuki Takei4, Masato Kusunoki1.   

Abstract

Orally administered Qing-dai, called indigo naturalis in Latin, is reportedly useful for the treatment of ulcerative colitis. We herein describe two patients with ulcerative colitis who developed colitis with wall thickening and edematous changes during oral administration of the powdered form of Qing-dai. In Case 1, a 35-year-old man developed colitis similar to ischemic colitis with bloody stool that recurred each time he ingested Qing-dai. He had no signs of recurrence upon withdrawal of Qing-dai. In Case 2, a 43-year-old woman underwent ileocecal resection for treatment of an intussusception 2 months after beginning oral administration of Qing-dai. Edema and congestion but no ulceration were present in the mucosa of the resected specimen. Both patients exhibited abdominal pain with bloody diarrhea, and abdominal computed tomography showed marked wall edema affecting an extensive portion of the large bowel.

Entities:  

Keywords:  Adverse effect; Colitis; Indigo naturalis; Intussusception; Qing-dai

Mesh:

Substances:

Year:  2018        PMID: 29549501     DOI: 10.1007/s12328-018-0851-7

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  19 in total

1.  Quality of herbal medicines: challenges and solutions.

Authors:  Junhua Zhang; Barbara Wider; Hongcai Shang; Xuemei Li; Edzard Ernst
Journal:  Complement Ther Med       Date:  2011-11-01       Impact factor: 2.446

2.  Placebo controlled evaluation of Xilei San, a herbal preparation in patients with intractable ulcerative proctitis.

Authors:  Ken Fukunaga; Yoshio Ohda; Nobuyuki Hida; Masaki Iimuro; Yoko Yokoyama; Koji Kamikozuru; Kazuko Nagase; Shiro Nakamura; Hiroto Miwa; Takayuki Matsumoto
Journal:  J Gastroenterol Hepatol       Date:  2012-12       Impact factor: 4.029

3.  Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

Authors:  Ju Qiu; Xiaohuan Guo; Zong-Ming E Chen; Lei He; Gregory F Sonnenberg; David Artis; Yang-Xin Fu; Liang Zhou
Journal:  Immunity       Date:  2013-08-15       Impact factor: 31.745

Review 4.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

5.  Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.

Authors:  Makoto Naganuma; Shinya Sugimoto; Keiichi Mitsuyama; Taku Kobayashi; Naoki Yoshimura; Hidehisa Ohi; Shinji Tanaka; Akira Andoh; Naoki Ohmiya; Keiichiro Saigusa; Takayuki Yamamoto; Yuichi Morohoshi; Hitoshi Ichikawa; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Kenji Watanabe; Shinta Mizuno; Wataru Suda; Masahira Hattori; Shinji Fukuda; Akiyoshi Hirayama; Takayuki Abe; Mamoru Watanabe; Toshifumi Hibi; Yasuo Suzuki; Takanori Kanai
Journal:  Gastroenterology       Date:  2017-11-22       Impact factor: 22.682

6.  Indigo Naturalis ameliorates murine dextran sodium sulfate-induced colitis via aryl hydrocarbon receptor activation.

Authors:  Shoichiro Kawai; Hideki Iijima; Shinichiro Shinzaki; Satoshi Hiyama; Toshio Yamaguchi; Manabu Araki; Shuko Iwatani; Eri Shiraishi; Akira Mukai; Takahiro Inoue; Yoshito Hayashi; Masahiko Tsujii; Daisuke Motooka; Shota Nakamura; Tetsuya Iida; Tetsuo Takehara
Journal:  J Gastroenterol       Date:  2016-11-29       Impact factor: 7.527

7.  [The endoscopic and clinical features of Indigo Naturalis-associated ischemic lesions of colonic mucosa].

Authors:  Bao-jun Suo; Li-ya Zhou; Shi-gang Ding; Yu-min Lü; Fang Gu; San-ren Lin; Ya-an Zheng
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2011-08

8.  Clinical Efficacy and Safety of Oral Qing-Dai in Patients with Ulcerative Colitis: A Single-Center Open-Label Prospective Study.

Authors:  Shinya Sugimoto; Makoto Naganuma; Hiroki Kiyohara; Mari Arai; Keiko Ono; Kiyoto Mori; Keiichiro Saigusa; Kosaku Nanki; Kozue Takeshita; Tatsuya Takeshita; Makoto Mutaguchi; Shinta Mizuno; Rieko Bessho; Yoshihiro Nakazato; Tadakazu Hisamatsu; Nagamu Inoue; Haruhiko Ogata; Yasushi Iwao; Takanori Kanai
Journal:  Digestion       Date:  2016-03-10       Impact factor: 3.216

9.  Therapeutic efficacy of the Qing Dai in patients with intractable ulcerative colitis.

Authors:  Hideo Suzuki; Tsuyoshi Kaneko; Yuji Mizokami; Toshiaki Narasaka; Shinji Endo; Hirofumi Matsui; Akinori Yanaka; Aki Hirayama; Ichinosuke Hyodo
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

10.  Monitoring heavy metals, residual agricultural chemicals and sulfites in traditional herbal decoctions.

Authors:  In-Sil Yu; Jeong-Sook Lee; Sung-Dan Kim; Yun-Hee Kim; Hae-Won Park; Hoe-Jin Ryu; Jib-Ho Lee; Jeong-Mi Lee; Kweon Jung; Cheol Na; Jin-Yong Joung; Chang-Gue Son
Journal:  BMC Complement Altern Med       Date:  2017-03-14       Impact factor: 3.659

View more
  3 in total

1.  Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide survey.

Authors:  Makoto Naganuma; Shinya Sugimoto; Hideo Suzuki; Yuichi Matsuno; Toshimitsu Araki; Hirotaka Shimizu; Ryohei Hayashi; Tomohiro Fukuda; Nobuhiro Nakamoto; Hideki Iijima; Shiro Nakamura; Masaharu Kataoka; Yuichi Tamura; Koichiro Tatsumi; Toshifumi Hibi; Yasuo Suzuki; Takanori Kanai
Journal:  J Gastroenterol       Date:  2019-05-17       Impact factor: 7.527

2.  Ischemic colitis induced by indigo naturalis in a patient with ulcerative colitis: a case report.

Authors:  Byungha Cho; Soon Man Yoon; Seung-Myoung Son; Hyoung Woo Kim; Ki Bae Kim; Sei Jin Youn
Journal:  BMC Gastroenterol       Date:  2020-05-15       Impact factor: 3.067

3.  Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trial.

Authors:  Kan Uchiyama; Shinichiro Takami; Hideo Suzuki; Kiyotaka Umeki; Satoshi Mochizuki; Nobushige Kakinoki; Junichi Iwamoto; Yoko Hoshino; Jun Omori; Shunji Fujimori; Akinori Yanaka; Yuji Mizokami; Toshifumi Ohkusa
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.